Volume | 8,431,778 |
|
|||||
News | - | ||||||
Day High | 15.98 | Low High |
|||||
Day Low | 15.69 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Walgreens Boots Alliance Inc | WBA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
15.81 | 15.69 | 15.98 | 15.84 | 15.86 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
46,154 | 8,431,778 | US$ 15.85 | US$ 133,614,727 | - | 14.62 - 32.87 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:59:16 | 1 | US$ 15.89 | USD |
Walgreens Boots Alliance (WBA) Options Flow Summary
Walgreens Boots Alliance Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
13.66B | 862.38M | - | 139.08B | -3.08B | -3.57 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Walgreens Boots Alliance News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical WBA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.35 | 16.34 | 15.34 | 16.07 | 13,689,993 | 0.46 | 3.00% |
1 Month | 17.26 | 18.83 | 14.62 | 16.46 | 13,231,487 | -1.45 | -8.40% |
3 Months | 20.57 | 22.05 | 14.62 | 18.09 | 12,264,966 | -4.76 | -23.14% |
6 Months | 21.50 | 27.05 | 14.62 | 21.09 | 13,422,975 | -5.69 | -26.47% |
1 Year | 31.53 | 32.87 | 14.62 | 22.77 | 12,301,214 | -15.72 | -49.86% |
3 Years | 54.85 | 55.82 | 14.62 | 32.61 | 8,505,944 | -39.04 | -71.18% |
5 Years | 51.24 | 65.00 | 14.62 | 37.45 | 7,600,149 | -35.43 | -69.15% |
Walgreens Boots Alliance Description
Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%). |